Showing results (2681-2690 of 4,889) with videos related to
Sort By:
Pageof 489
Science Translational Medicine|March 2, 2022
Modeling genetic diseases in nonhuman primates through embryonic and germline modification: Considerations and challengesJenna K Schmidt, Kathryn M Jones, Trevor Van Vleck, et al.Science Translational Medicine|March 2, 2022
A carcinoembryonic antigen-specific cell therapy selectively targets tumor cells with HLA loss of heterozygosity in vitro and in vivoMark L Sandberg, Xueyin Wang, Aaron D Martin, et al.Science Translational Medicine|March 9, 2022
Innate PD-L1 limits T cell-mediated adipose tissue inflammation and ameliorates diet-induced obesityChristian Schwartz, Viviane Schmidt, Andrea Deinzer, et al.Science Translational Medicine|August 10, 2018
Laminin 511 is a target antigen in autoimmune pancreatitisMasahiro Shiokawa, Yuzo Kodama, Kiyotoshi Sekiguchi, et al.Science Translational Medicine|September 3, 2025
Inhibiting SLC38A2 lowers blood pressure in rodent models of hypertensionChunxiu Du, Hu Xu, Wenqian Zhao, et al.Science Translational Medicine|September 3, 2025
Comprehensive analysis of microbial content in whole-genome sequencing samples from The Cancer Genome Atlas projectYuchen Ge, Jennifer Lu, Daniela Puiu, et al.Science Translational Medicine|September 3, 2025
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteinsSanjeev Kumar, Shilpi Jain, Bushra Wali, et al.Science Translational Medicine|April 23, 2010
Drug resistance, epigenetics, and tumor cell heterogeneityTimothy HoeyScience Translational Medicine|April 23, 2010
Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's diseaseMohamed R Ahmed, Amandine Berthet, Evgeny Bychkov, et al.Science Translational Medicine|April 29, 2010
Toward an oligonucleotide therapy for Duchenne muscular dystrophy: a complex development challengeMatthew J A WoodPageof 489